Literature DB >> 1290637

Epidemiology on malignant melanoma in Europe.

A Osterlind1.   

Abstract

Mortality and incidence of malignant melanoma of the skin is increasing at a rate of between 3 and 7% per year in many European countries. All over Europe melanoma is the cancer showing the most rapid increase in incidence. Within Europe the variation in incidence and mortality rates is close to a factor of ten with the disease being more common in northern than in southern Europe. Higher rates are consistently reported on intermittently exposed body sites. Skin melanoma differ from non-melanoma skin cancer with regard to sex-, age-, and anatomic distribution. There is mounting evidence from analytical studies that the increase in melanoma incidence is a result of intermittent recreational sun exposure. Severe sunburns, in particular, is a strong risk factor, being especially harmful in childhood. Outdoor work with chronic sun exposure is not associated with increased melanoma risk and it may even be protective. The total number of pigmented naevi is an important risk factor in several studies. Freckling, fair complexion, and skin which burns rather than tans at sun exposure, are other well-established risk factors. Today no non-solar environmental risk factors have been identified. Information campaigns based on our knowledge of risk factors, warning against excessive sun exposure should significantly reduce the incidence in the future. Population-based education of risk groups may lead to earlier diagnosis and thereby reduced mortality.

Entities:  

Mesh:

Year:  1992        PMID: 1290637     DOI: 10.3109/02841869209089727

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  6 in total

1.  Analysis of association between sunscreens use and risk of malignant melanoma.

Authors:  Fang Xie; Tingting Xie; Qi Song; Shan Xia; Hengjin Li
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  [Socio-legal evaluation of UV-induced skin tumors].

Authors:  S Völter-Mahlknecht; M Berneburg; D-M Rose; H Drexler; M Röcken; S Letzel; W Wehrmann
Journal:  Hautarzt       Date:  2005-08       Impact factor: 0.751

Review 3.  Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature.

Authors:  Gery P Guy; Donatus U Ekwueme
Journal:  Pharmacoeconomics       Date:  2011-10       Impact factor: 4.981

4.  A pilot study on morphology and the mechanism involved in linearly patterned programmed cell necrosis in melanoma.

Authors:  Chunrong Han; Baoc Un Sun; Wei Wang; Wen Juan Cai; Dan Lou; Yan Sun; Xiulan Zhao
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

5.  Use of topical sunscreens and the risk of malignant melanoma: a meta-analysis of 9067 patients from 11 case-control studies.

Authors:  Michael Huncharek; Bruce Kupelnick
Journal:  Am J Public Health       Date:  2002-07       Impact factor: 9.308

6.  High prevalence of skin diseases and need for treatment in a middle-aged population. A Northern Finland Birth Cohort 1966 study.

Authors:  Suvi-Päivikki Sinikumpu; Laura Huilaja; Jari Jokelainen; Markku Koiranen; Juha Auvinen; Päivi M Hägg; Erika Wikström; Markku Timonen; Kaisa Tasanen
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.